314 search results
- Current search:
- Schizophrenia
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
NewCochrane EvidencePublished 20 Jul 2017
Haloperidol versus risperidone for schizophrenia
Protocol: To review the clinical effectiveness and safety of haloperidol compared with risperidone for people with schizophrenia. -
NewCochrane EvidencePublished 28 Jun 2017
Combining antipsychotic medication for the treatment of schizophrenia
Background Antipsychotic medication was introduced in the 1950s to reduce or alleviate the symptoms of schizophrenia, such as the psychotic states of hearing voices, visual hallucinations and strange thoughts such as paranoia (feeling singled-out or put upon by others). Medication for mental illness also helped to establish care in the community, ... -
NewCochrane EvidencePublished 28 Jun 2017
Wendan decoction for schizophrenia
Review question Is there trial-based evidence that a traditional Chinese herbal medicine, Wendan decoction (WDD) is effective for treatment of people with schizophrenia? Background Schizophrenia is a severe mental illness, characterised by profound disruptions in thinking that affects language, perception, and sense of self. People with schizophrenia ... -
NewCochrane EvidencePublished 17 Jun 2017
Magnetic seizure therapy for people with schizophrenia
Protocol: To estimate the effects of magnetic seizure therapy (MST) alone compared with sham MST or with standard care or any other comparators for schizophrenia. -
NewCochrane EvidencePublished 14 Jun 2017
Clozapine dose in schizophrenia
Background: Schizophrenia is a severe mental illness that affects thinking and perception. People with schizophrenia often experience profound disruptions in their speech, emotional processes, behaviour and sense of self. Antipsychotic medication can be a helpful treatment for schizophrenia; however, taking antipsychotic medication can have unpleasant ... -
NewCochrane EvidencePublished 13 Jun 2017
Communication skills training for mental health professionals working with people with severe mental illness
Question Does communication skills training for mental health professionals benefit their patients with severe mental illness? Background Severe mental illness (such as schizophrenia or schizoaffective disorder) is a mental, behavioural or emotional disorder which severely interferes with, or limits a person’s life activities for a prolonged time ... -
Cochrane EvidencePublished 29 May 2017
Music therapy for schizophrenia or schizophrenia-like disorders
Review Question What are the effects of providing music therapy or adding music therapy to treatment for people with schizophrenia or schizophrenia-like disorders? Background Characteristics of schizophrenia and schizophrenia-like disorders are disordered thoughts, feelings, beliefs and perceptions. People with schizophrenia often have two main ... -
TitlePublished 7 May 2017
Antipsychotic medication for catatonic schizophrenia
Schizophrenia Group Stanley Caroff Title Friday, May 5, 2017 ... -
Cochrane EvidencePublished 13 Apr 2017
Chlorpromazine dose for people with schizophrenia
Review question This review looks at the best dose of chlorpromazine for treating people with schizophrenia. Background Schizophrenia is a serious mental illness affecting around 1% of the adult population worldwide. People with schizophrenia often hear voices or see things (hallucinations) and have strange beliefs (delusions). The main treatment ... -
Cochrane EvidencePublished 7 Apr 2017
Direct comparison of two antipsychotics (chlorpromazine versus clotiapine) for treating schizophrenia
Review question The aim of this review was to find good quality evidence comparing the efficacy of chlorpromazine versus clotiapine for schizophrenia. Background Chlorpromazine is one of the first antipsychotics to successfully alleviate the symptoms of psychosis. It was introduced in the 1950s and is still one of the most commonly used antipsychotics. ...
